ICAM1 and diabetic retinopathy: As previous reported, an increase in serum VEGF, intercellular cell adhesion molecule (ICAM)-1, and antimyeloperoxidase antibody levels are associated with an increase in the severity of diabetic retinopathy and the grade of external limiting membrane and EZ disruption as well as decreased visual acuity in diabetic retinopathy.